human coagulation factor viii
UkraineDrugs containing this active substance
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency), as well as for the correction of acquired factor VIII deficiency. It is also used for the prevention and treatment of bleeding in von Willebrand disease if desmopressin treatment is ineffective or contraindicated.
Form: lyophilisate for solution for injection
Active substance Dosage human coagulation factor viii 500 IU human von willebrand factor 250 IU ATC: B02BD06
Manufacturer: Biopharma Plazma LLC (manufacturing, primary and secondary packaging, quality control, batch release)
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A, as well as for the correction of acquired factor VIII deficiency. It is also used for the prevention and treatment of bleeding in von Willebrand disease if desmopressin is ineffective or contraindicated.
Form: lyophilisate for solution for injection
Active substance Dosage human coagulation factor viii 250 IU human von willebrand factor 125 IU ATC: B02BD06
Manufacturer: Biopharma Plazma LLC (manufacturing, primary and secondary packaging, quality control, batch release)
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A, as well as for the correction of acquired factor VIII deficiency. It is also used for the treatment or prevention of bleeding in von Willebrand disease if desmopressin is ineffective or contraindicated.
Form: lyophilisate for solution for injection
Active substance Dosage human coagulation factor viii 1000 IU human von willebrand factor 500 IU ATC: B02BD06
Manufacturer: Biopharma Plazma LLC (manufacturing, primary and secondary packaging, quality control, batch release)